Biotech SF: Via Pharmaceuticals

Showing posts with label Via Pharmaceuticals. Show all posts

Monday, June 13, 2011

Via starts cholesterol treatment trial

Via Pharmaceuticals Inc. started an early safety test of a treatment for high LDL cholesterol.
The San Francisco drug company (Pink Sheets: VIAP) is testing the drug VIA-3196 in healthy volunteers at a center in Fargo, N.D. There will ultimately be about 72 people in this test. They’ll each get a single dose of the drug.

Subscribe to: Posts (Atom)

Some of my favorite stories.

• "The fight of his life" (2007)

Last year Mike Homer helped raise the money for 2,000 medical research computers. Now researchers are using that equipment in an attempt to save his life.

• "For reporter, CJD is more than a story" (2007)

Seven years ago -- nearly to the day -- my mother died of Creutzfeld-Jakob Disease.

• "A son's YouTube plea for Avastin" (2010)

Josh Turnage is your typical teenager, trying to discover what he wants to do in college and with his life. But a 7-minute, 41-second YouTube video he produced about his mother's fight with breast cancer may thrust him into a debate between drug makers and the agency that regulates them.

• "New device could knock out old dialysis technology" (2011)

Shuvo Roy has all the makings for the world's first implantable artificial kidney, thanks to nanotechnology and a web of nationwide collaborations.

All he needs now is $20 million.